Understanding risk factors for Parkinson's disease through participant reports
Parkinson's Progression Markers Initiative Online Study (PPMI Online)
This study is trying to find out what factors might increase the risk of getting Parkinson's disease by gathering information from people with and without the condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Michael J. Fox Foundation for Parkinson's Research Academic / other |
| Locations | 1 site (San Francisco, California) |
| Trial ID | NCT05065060 on ClinicalTrials.gov |
What this trial studies
The Parkinson Progression Marker Initiative Online (PPMI Online) is an observational study that collects information from individuals with and without Parkinson's disease to identify risk and predictive factors associated with the condition. This initiative is part of a larger program aimed at discovering markers of disease progression, which can be utilized in clinical trials for therapies targeting the reduction of Parkinson's disability. Participants may be involved in various related protocols, enhancing the breadth of data collected for analysis.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older, both those diagnosed with Parkinson's disease and those without a diagnosis.
Not a fit: Patients who are under 18 years old or those with other neurodegenerative disorders unrelated to Parkinson's disease may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and early identification of Parkinson's disease, potentially guiding preventive strategies and treatments.
How similar studies have performed: Other studies focusing on participant-reported outcomes in neurodegenerative diseases have shown promise, indicating that this approach could yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Parkinson Disease (PD) Participants: * Male or female age 18 years or older. * Has received a diagnosis of Parkinson's disease Participants without PD: * Male or female age 18 years or older. * Has not received a diagnosis of Parkinson's disease
Where this trial is running
San Francisco, California
- UCSF Movement Disorders and Neuromodulation Center (MDNC) — San Francisco, California, United States (Recruiting)
Study contacts
- Principal investigator: Caroline Tanner, MD, PhD — University of California, San Francisco
- Study coordinator: University of California, San Francisco
- Email: info@ppmionline.org
- Phone: 877-525-7764
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.